Oramed Pharmaceuticals, Inc. (ORMP)
3.68
-0.01
(-0.27%)
USD |
NASDAQ |
Jan 16, 16:00
3.52
-0.16
(-4.35%)
After-Hours: 07:23
Oramed Pharmaceuticals EPS Diluted (Quarterly): 1.131 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifeward Ltd. | -0.1979 |
| Bristol Myers Squibb Co. | 1.079 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 48.39M |
| Total Expenses (Quarterly) | -48.40M |
| Enterprise Value | 11.69M |
| Earnings Yield | 27.25% |
| Normalized Earnings Yield | 15.18 |